ARCHIVES

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000